From genes to public health: the applications of genetic technology in disease prevention. Genetics Working Group.
- 1 December 1996
- journal article
- review article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 86 (12) , 1717-1722
- https://doi.org/10.2105/ajph.86.12.1717
Abstract
With advances in the Human Genome Project, the implications of genetic technology in disease prevention should be assessed. The paradigm suggested in The Future of Public Health--assessment, policy development, and assurance--was used to examine the continuum from genetic technology to public health practice. First, important public health functions are to (1) assess the impact of genes and their interactions with modifiable disease risk factors on the health status of the population and (2) assess the impact and safety of genetic testing on the population. Second, given the many implications of genetic testing, the public health community should participate in policy development related to the timing and use of genetic testing in disease prevention. Third, whenever appropriate, the public health community needs to ensure the development of public health genetics programs (e.g. newborn screening) and evaluate the quality and effectiveness of the use of genetic testing in disease prevention. Although most current genetic tests are not ready for disease prevention, there is an important role for the public health community in translating genetic technology into disease prevention.Keywords
This publication has 55 references indexed in Scilit:
- Molecular genetic approaches to understanding brain development and behaviourPsychoneuroendocrinology, 1994
- Four‐marker serum screening for Down's syndromePrenatal Diagnosis, 1994
- Statement on use of DNA testing for presymptomatic identification of cancer risk. National Advisory Council for Human Genome ResearchPublished by American Medical Association (AMA) ,1994
- Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection NetworkPublished by American Medical Association (AMA) ,1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Inherited breast and ovarian cancer. What are the risks? What are the choices?Published by American Medical Association (AMA) ,1993
- Genetic testing in the workplace: a view from the USATrends in Genetics, 1992
- Genetics and Public Health in the 1990sAnnual Review of Public Health, 1990
- Pharmacogenetics: Past and futureLife Sciences, 1990
- Prophylaxis with Oral Penicillin in Children with Sickle Cell AnemiaNew England Journal of Medicine, 1986